# C-Type Lectins and Immune Surveillance in ALD

> **NIH NIH K99** · CLEVELAND CLINIC LERNER COM-CWRU · 2021 · $61,569

## Abstract

Project Summary
This Administrative Supplement will provide an additional year of mentored research to compensate for
research progress and career development that was delayed due to the COVID-19 pandemic. The pandemic
forced research labs at the Cleveland Clinic to reduce to a quarter or half capacity for the last year, reduced the
number of patients enrolled in studies, and decreased access to many critical lab supplies including reagents.
As a result, research focus had to be shifted to remote work, and many year 1 and year 2 research and career
goals for the K99 were unmet. During this extra year, the candidate will be able to finish experiments that were
put off due to the pandemic and continue to develop skills in clinical immunology, generate the sequencing data
outlined in the proposal, and learn leadership skills to transition into independence.

## Key facts

- **NIH application ID:** 10426861
- **Project number:** 3K99AA028048-02S1
- **Recipient organization:** CLEVELAND CLINIC LERNER COM-CWRU
- **Principal Investigator:** Adam Kim
- **Activity code:** K99 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $61,569
- **Award type:** 3
- **Project period:** 2021-09-01 → 2022-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10426861

## Citation

> US National Institutes of Health, RePORTER application 10426861, C-Type Lectins and Immune Surveillance in ALD (3K99AA028048-02S1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10426861. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*